Omalizumab induced Takotsubo syndrome : case report
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10451/40043 |
Resumo: | © The Author(s) 2019.The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
id |
RCAP_671ebabcb28a9c6dab63d92ceb00cb58 |
---|---|
oai_identifier_str |
oai:repositorio.ul.pt:10451/40043 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Omalizumab induced Takotsubo syndrome : case reportTakotsubo syndromeOmalizumabCase reportLeft ventricular dysfunction© The Author(s) 2019.The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.comBackground: Omalizumab is a humanized monoclonal anti-immunoglobulin E antibody, approved for the treatment of spontaneous chronic urticaria, with high efficacy and an excellent safety profile. Although its adverse effects are rare, allergic reactions and cardiovascular events were previously described. Case summary: The authors describe the case of a 75-year-old woman, followed at the outpatient dermatology clinic due to spontaneous chronic urticaria, treated with omalizumab 300 mg every 4 weeks. After the 11th administration of omalizumab, the patient developed an episode of thoracalgia associated with electro- and echocardiographic abnormalities. Coronary angiogram excluded coronary artery disease, and left ventriculography demonstrated mid-apical akinesia and basal hyperkinesia, consistent with the Takotsubo syndrome (TS). Discussion: Takotsubo syndrome was already reported in association with other monoclonal antibodies. However, to our knowledge, this is the first case of TS following the administration of omalizumab.Oxford University PressRepositório da Universidade de LisboaAguiar-Ricardo, InêsNunes-Ferreira, AfonsoRoda, ÂngelaRosario, Luis2019-11-04T15:57:54Z20192019-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10451/40043engEuropean Heart Journal - Case Reports, Volume 3, Issue 1, March 2019, yty1552514-211910.1093/ehjcr/yty155info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-08T16:39:05Zoai:repositorio.ul.pt:10451/40043Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:53:46.022895Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Omalizumab induced Takotsubo syndrome : case report |
title |
Omalizumab induced Takotsubo syndrome : case report |
spellingShingle |
Omalizumab induced Takotsubo syndrome : case report Aguiar-Ricardo, Inês Takotsubo syndrome Omalizumab Case report Left ventricular dysfunction |
title_short |
Omalizumab induced Takotsubo syndrome : case report |
title_full |
Omalizumab induced Takotsubo syndrome : case report |
title_fullStr |
Omalizumab induced Takotsubo syndrome : case report |
title_full_unstemmed |
Omalizumab induced Takotsubo syndrome : case report |
title_sort |
Omalizumab induced Takotsubo syndrome : case report |
author |
Aguiar-Ricardo, Inês |
author_facet |
Aguiar-Ricardo, Inês Nunes-Ferreira, Afonso Roda, Ângela Rosario, Luis |
author_role |
author |
author2 |
Nunes-Ferreira, Afonso Roda, Ângela Rosario, Luis |
author2_role |
author author author |
dc.contributor.none.fl_str_mv |
Repositório da Universidade de Lisboa |
dc.contributor.author.fl_str_mv |
Aguiar-Ricardo, Inês Nunes-Ferreira, Afonso Roda, Ângela Rosario, Luis |
dc.subject.por.fl_str_mv |
Takotsubo syndrome Omalizumab Case report Left ventricular dysfunction |
topic |
Takotsubo syndrome Omalizumab Case report Left ventricular dysfunction |
description |
© The Author(s) 2019.The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-11-04T15:57:54Z 2019 2019-01-01T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10451/40043 |
url |
http://hdl.handle.net/10451/40043 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
European Heart Journal - Case Reports, Volume 3, Issue 1, March 2019, yty155 2514-2119 10.1093/ehjcr/yty155 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Oxford University Press |
publisher.none.fl_str_mv |
Oxford University Press |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799134476180127744 |